{"title":"The Invisible Variables: Why Clonal Systems are not Immune to Environmental Confounding.","authors":"Onishi Tatsuki","doi":"10.1007/s12015-026-11239-w","DOIUrl":"https://doi.org/10.1007/s12015-026-11239-w","url":null,"abstract":"","PeriodicalId":21955,"journal":{"name":"Stem Cell Reviews and Reports","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148930922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bulge Progenitor Cells: A Promising Frontier in Hair Follicle Regeneration and Clinical Translation.","authors":"Mamata Mishra, Rinky Kapoor, Maushmi S Kumar, Debraj Shome, Ashwin Prabhughate","doi":"10.1007/s12015-026-11232-3","DOIUrl":"https://doi.org/10.1007/s12015-026-11232-3","url":null,"abstract":"<p><strong>Highlight: </strong>• Bulge progenitors' cells (BPC) are multipotent cells that fuel hair follicle cycling, sebaceous turnover, and epidermal repair.• BPC activation from quiescence is governed by niche-derived Wnt/β-catenin (anagen entry), BMP antagonism (licensing transit), and TGF-β/Smad (catagen enforcement).• Preclinical models demonstrate de novo folliculogenesis using BPC- dermal papilla cell recombinants in 3D scaffolds, with > 70% graft viability and restored cyclic hair growth.• Early-phase clinical trials of autologous BPC-enriched micrografts report 20-30% increases in hair density in androgenetic alopecia, with minimal adverse events.• Translational realization demands GMP-compliant isolation, biomimetic niche engineering (hydrogels, bioprinting), and immunomodulatory strategies to ensure safety, scalability, and durability.</p>","PeriodicalId":21955,"journal":{"name":"Stem Cell Reviews and Reports","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rinky Kapoor, Raji Patil, Debraj Shome, Prashant Anilkumar Singh, Sukesh M S, Imran Ali
{"title":"\"Targeted Reconstitution of Follicular Signaling in Alopecia: Extending a Six-Factor Biomimetic Polypeptide Suite with BMP Antagonism, HGF, and SCF - the Zenith of Engineered Orchestration\".","authors":"Rinky Kapoor, Raji Patil, Debraj Shome, Prashant Anilkumar Singh, Sukesh M S, Imran Ali","doi":"10.1007/s12015-026-11223-4","DOIUrl":"https://doi.org/10.1007/s12015-026-11223-4","url":null,"abstract":"","PeriodicalId":21955,"journal":{"name":"Stem Cell Reviews and Reports","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148887494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Temur Nasibov, Anna Gorokhova, Igor Khlusov, Kristina Yurova, Larisa Litvinova, Alex Volinsky
{"title":"The Nitinol Stented Vessels: Integrating Pathological Triad of Inflammation, Hypoxia and Mechanical Stress to Rethink Endothelial Protection.","authors":"Temur Nasibov, Anna Gorokhova, Igor Khlusov, Kristina Yurova, Larisa Litvinova, Alex Volinsky","doi":"10.1007/s12015-026-11226-1","DOIUrl":"https://doi.org/10.1007/s12015-026-11226-1","url":null,"abstract":"","PeriodicalId":21955,"journal":{"name":"Stem Cell Reviews and Reports","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148881337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond Remission: Risk-Adapted Maintenance and Mechanism-Guided Salvage After CAR T-Cell Therapy for Multiple Myeloma.","authors":"Shuai Su, Sijia Yan, Jiaying Wu, Yi Xiao","doi":"10.1007/s12015-026-11228-z","DOIUrl":"https://doi.org/10.1007/s12015-026-11228-z","url":null,"abstract":"<p><strong>Background: </strong>B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell therapy can induce deep responses in relapsed or refractory multiple myeloma, yet relapse remains frequent. Neither post-infusion maintenance nor salvage after CAR T-cell failure has an established standard.</p><p><strong>Main text: </strong>This review synthesizes pivotal trials, real-world cohorts, and translational studies into a risk-adapted framework for longitudinal care. Relapse biology, target modulation, CAR T-cell persistence, immune reconstitution, measurable residual disease (MRD), and imaging are integrated to guide structured observation, time-limited maintenance, pre-emptive intervention, and salvage. Preventive treatment is defensible only when the estimated risk posed by residual disease exceeds the competing risks of infection, cytopenia, and delayed immune recovery. At relapse, treatment selection should begin with clinical tempo, disease compartment, contemporary expression of BCMA, G protein-coupled receptor class C group 5 member D (GPRC5D), and Fc receptor-homolog 5 (FcRH5), prior target pressure, and host immune fitness.</p><p><strong>Conclusions: </strong>Structured observation is appropriate for many patients with sustained MRD negativity, no extramedullary disease, and recovering immune function. Persistent or rising MRD, residual lesions, aggressive disease biology, or unfavorable CAR T-cell kinetics should prompt early trial referral rather than automatic chronic therapy. Salvage may involve BCMA retargeting, a switch to GPRC5D or FcRH5, conventional cytoreduction, radiotherapy, antibody-drug conjugates, bispecific antibodies, or a second cellular platform. Future trials should assess progression-free survival together with infection-free survival, treatment-free interval, immune recovery, quality of life, and responsiveness to subsequent salvage.</p>","PeriodicalId":21955,"journal":{"name":"Stem Cell Reviews and Reports","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148881312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}